- Advantages of using a data-focused CRO and technology to manage data related activities
- Simplifying process and leveraging efficiencies to reduce risk and cost
- Understand key gateways to ensure quality and coordination
- Sponsor perspective and benefits of outsourcing models
- Patient identification: how to find patients who are eligible to participate in your rare disease trial
- Collaborating with patient advocacy groups to facilitate recruitment
- How does recruitment in rare diseases differ from other therapeutic areas?
- Using eConsent as a tool to speed up recruitment and thus overall trial timelines
- The regulatory landscape surrounding eConsent: what challenges are there to this?
- Maintaining a relationship with patients in order to ensure consent is informed in remote settings
- Reviewing results from our annual survey: were 2024 predictions correct?
- Key themes and technology advancements in biopharma
- Spotlight on clinical trial technologies for drug development
- Leveraging data to predict the outlook for 2025 clinical trial outsourcing
- Trends, key players, opportunities and threat in biopharma
- What the latest investment trends show for small to medium biotechs
- Understanding the requirement and options for declaring biological materials to U.S. Customs and Border Protection (CBP)
- Review of key U.S. regulatory agency authorities, such as CDC, FDA, USDA, and CBP
- Discovering the latest non-compliant shipment issues for biological materials and pharma products and tips to avoid them
- Learning about valuable resources and contacts for assistance
